Depends. If this new CEO can go out and sign a few contracts worth millions, then it is really cheap. But if he can only sign contracts worth in the thousands, then yeah Only time will tell.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025